CompletedPhase 2NCT02199509
Efficacy of Levetiracetam in Oromandibular and Cranial Dystonia
Studying Oromandibular dystonia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Principal Investigator
- Mark Hallett, M.D., MDNational Institute of Neurological Disorders and Stroke (NINDS)
- Intervention
- Levetiracetam(drug)
- Enrollment
- 8 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2014 – 2016
Study locations (1)
- National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02199509 on ClinicalTrials.gov